Correction: Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults

Mohraz M, Salehi M, Tabarsi P, et al. Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults. BMJ Open 2022;12:e056872. doi: 10.1136/bmjopen-2021-...

Full description

Saved in:
Bibliographic Details
Published in:BMJ open 2022-11, Vol.12 (11), p.e056872corr1-e056872corr1
Format: Article
Language:English
Subjects:
Correction
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mohraz M, Salehi M, Tabarsi P, et al. Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults. BMJ Open 2022;12:e056872. doi: 10.1136/bmjopen-2021-056872
ISSN:2044-6055
2044-6055
DOI:10.1136/bmjopen-2021-056872corr1